Catalyst Wire Dossier Catalyst Wire Dossier

Phleum pratense oral lyophilisate

Phleum pratense oral lyophilisate · ALK-Abelló A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Phleum pratense oral lyophilisate, covering 2017-06-28 to 2017-06-28. Get the full timeline:

Most recent: Clinical Trial Update: Molecular and Cellular Mechanism in the Course of Immunotherapy With a Phleum Pratense Oral Lyophilisate [Phase 4]

See pricing